TY - JOUR
T1 - Effects of the N-Methyl-D-Aspartate Receptor on Temporal Summation of Second Pain (Wind-up) in Irritable Bowel Syndrome
AU - Zhou, Qiqi
AU - Price, Donald D.
AU - Callam, Christopher S.
AU - Woodruff, Michael A.
AU - Verne, G. Nicholas
N1 - Funding Information:
Supported by an NIH grant ( NIH RO1-NS053090 ) to G.N. Verne and by a VA Merit Review Award to G.N. Verne from the Medical Research Service of the Department of Veterans Affairs. The authors have no financial or other relationship to the report that might lead to a conflict of interest.
PY - 2011/2
Y1 - 2011/2
N2 - Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in which the pathophysiological mechanisms of the pain and hypersensitivity are not well understood. IBS patients frequently complain of pain in body regions somatotopically distinct from the gut, suggesting that central hyperalgesic mechanisms may be involved. In the current study, during the wind-up testing session, a series of 6 heat pulses were presented with an interstimulus interval (ISI) of 3 seconds. Following the 1st, 3rd, and 6th thermal stimuli, subjects were asked to rate the late thermal sensation or second pain. IBS patients who demonstrated temporal summation of pain (TSSP) then received dextromethorphan and placebo in a randomized, double-blind, fashion to block wind-up. The results showed: 1) a subset of IBS patients, but not controls, showed TSSP in response to a series of noxious heat pulses; and 2) TSSP was blocked by administration of dextromethorphan, an NMDA receptor antagonist. In summary, these findings further elucidate mechanisms of somatic hypersensitivity in a subset of IBS patients. Our results also support an etiologic basis for abnormal NMDA receptor mechanisms in some IBS patients. Future studies are needed to determine if NMDA receptor antagonists may be used to treat IBS patients. Perspective: This study evaluates temporal summation of second pain in a subset of IBS patients that is blocked by Dextromethorphan, an NMDA receptor antagonist. Theses results could lead to the use of an NMDA receptor antagonist in the treatment of pain in a subset of IBS patients.
AB - Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in which the pathophysiological mechanisms of the pain and hypersensitivity are not well understood. IBS patients frequently complain of pain in body regions somatotopically distinct from the gut, suggesting that central hyperalgesic mechanisms may be involved. In the current study, during the wind-up testing session, a series of 6 heat pulses were presented with an interstimulus interval (ISI) of 3 seconds. Following the 1st, 3rd, and 6th thermal stimuli, subjects were asked to rate the late thermal sensation or second pain. IBS patients who demonstrated temporal summation of pain (TSSP) then received dextromethorphan and placebo in a randomized, double-blind, fashion to block wind-up. The results showed: 1) a subset of IBS patients, but not controls, showed TSSP in response to a series of noxious heat pulses; and 2) TSSP was blocked by administration of dextromethorphan, an NMDA receptor antagonist. In summary, these findings further elucidate mechanisms of somatic hypersensitivity in a subset of IBS patients. Our results also support an etiologic basis for abnormal NMDA receptor mechanisms in some IBS patients. Future studies are needed to determine if NMDA receptor antagonists may be used to treat IBS patients. Perspective: This study evaluates temporal summation of second pain in a subset of IBS patients that is blocked by Dextromethorphan, an NMDA receptor antagonist. Theses results could lead to the use of an NMDA receptor antagonist in the treatment of pain in a subset of IBS patients.
KW - Irritable bowel syndrome
KW - central sensitization
KW - nociceptive stimuli
KW - repetitive afferent barrage
KW - temporal summation of second pain
KW - visceral and thermal hypersensitivity
KW - wind-up
UR - http://www.scopus.com/inward/record.url?scp=79551603862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551603862&partnerID=8YFLogxK
U2 - 10.1016/j.jpain.2010.09.002
DO - 10.1016/j.jpain.2010.09.002
M3 - Article
C2 - 21146468
AN - SCOPUS:79551603862
SN - 1526-5900
VL - 12
SP - 297
EP - 303
JO - Journal of Pain
JF - Journal of Pain
IS - 2
ER -